xbrli:pureiso4217:DKK242420052021-01-012021-12-31242420052021-01-012021-12-311242420052021-01-012021-12-311242420052021-01-012021-12-311242420052021-01-012021-12-312242420052021-01-012021-12-313242420052021-01-012021-12-31242420052020-01-012020-12-31242420052021-01-012021-12-31fsa:ProposedDividendRecognisedInEquityMember242420052020-01-012020-12-31fsa:ProposedDividendRecognisedInEquityMember242420052021-01-012021-12-31fsa:RetainedEarningsMember242420052020-01-012020-12-31fsa:RetainedEarningsMember242420052021-01-012021-12-31fsa:RetainedEarningsMember242420052021-01-012021-12-31fsa:ProposedDividendRecognisedInEquityMember242420052021-12-31242420052020-12-31242420052021-01-01fsa:ContributedCapitalMember242420052021-01-01fsa:ReserveForDevelopmentExpenditureMember242420052021-01-01fsa:RetainedEarningsMember242420052021-01-01fsa:ProposedDividendRecognisedInEquityMember242420052021-01-01242420052021-12-31fsa:ContributedCapitalMember242420052021-12-31fsa:ReserveForDevelopmentExpenditureMember242420052021-12-31fsa:RetainedEarningsMember242420052021-12-31fsa:ProposedDividendRecognisedInEquityMember242420052021-01-012021-12-31fsa:ReserveForDevelopmentExpenditureMemberGrundlag for konklusionKonklusiontrue2022-02-162022-02-162020-01-012020-12-3133963556København S23006WeidekampsgadeDeloitte Statsautoriseret RevisionspartnerselskabGentofteHellerup2900Regnskabsklasse BErklæring om udvidet gennemgang2021-12-312021-01-01<br /><br />20KildegårdsvejCareCom A/S24242005339635562300 København SWeidekampsgade 6Deloitte Statsautoriseret RevisionspartnerselskabÅrsrapportThe Board of Directors and the Executive Board have today considered and approved the annual report of CareCom A/S for the financial year 01.01.2021 - 31.12.2021.The annual report is presented in accordance with the Danish Financial Statements Act.In our opinion, the financial statements give a true and fair view of the Entity’s financial position at 31.12.2021 and of the results of its operations for the financial year 01.01.2021 - 31.12.2021.We believe that the management commentary contains a fair review of the affairs and conditions referred to therein.We recommend the annual report for adoption at the Annual General Meeting.HellerupJacob Boye HansenFlemming Jack Claus HansenJacob Boye HansenTorben SkovnæstformandformandTo the shareholders of CareCom A/SWe have performed an extended review of the financial statements of CareCom A/S for the ​financial year 01.01.2021 - 31.12.2021, which comprise the income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. ​Based on our extended review, in our opinion, the financial statements give a true and fair view of the Entity’s ​financial position at. 31.12.2021 and of the results of its operations for the financial year 01.01.2021 - 31.12.2021 in accordance with the Danish Financial Statements Act.We conducted our extended review in accordance with the assurance engagement standard for small enterprises as issued by the Danish Business Authority and the standard on extended review of financial statements prepared in accordance with the Danish Financial Statements Act as issued by FSR - Danish Auditors. Our responsibilities under those standards and requirements are further described in the ”Auditor’s responsibilities for the extended review of the financial statements” section. We are independent of the Entity in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the evidence we have obtained is sufficient and appropriate to provide a basis for our conclusion.Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, Management is responsible for assessing the Entity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern, and using the going concern basis of accounting unless Management either intends to liquidate the Entity or to cease operations, or has no realistic alternative but to do so.Our responsibility is to express a conclusion on the financial statements. This requires that we plan and perform procedures to obtain limited assurance about our conclusion on the financial statements and that we also perform specifically required supplementary procedures for the purpose of obtaining additional assurance about our conclusion. An extended review consists of making inquiries, primarily of management and, if appropriate, of other entity personnel, performing analytical and the specifically required supplementary procedures as well as evaluating the evidence obtained. The procedures performed in an extended review are less in scope than in an audit, and accordingly we do not express an audit opinion on the financial statements.Management is responsible for the management commentary. Our conclusion on the financial statements does not cover the management commentary, and we do not express any form of assurance conclusion thereon. In connection with our extended review of the financial statements our responsibility is to read the management commentary and, in doing so, consider whether the management commentary is materially inconsistent with the financial statements or our knowledge obtained in the extended review or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the management commentary provides the information required under the Danish Financial Statements Act.<br />Based on the work we have performed, we conclude that the management commentary is in accordance with financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management commentary.CopenhagenClaus Jorch Andersenmne33712State Authorised Public AccountantFinancial highlights2021 DKK'0002020 DKK'0002019 DKK'0002018 DKK'0002017 DKK'000Key figuresGross profit/loss24,41512,80915,6419,9648,504Operating profit/loss16,5605,0677,9222,9261,922Net financials514752117(404)Profit/loss for the year13,2874,8916,6651,819356Total assets19,93815,17421,67017,31014,236Investments in property, plant and equipment04923641215Equity14,7199,43114,5409,6757,858EBITDA Group level17,6026,6648,8064,4433,023RatiosEquity ratio (%)73.8262.1567.1055.8955.20Financial highlights are defined and calculated in accordance with the current version of "Recommendations & Ratios" issued by the CFA Society Denmark.Return on equity (%) :Equity ratio (%) :Equity * 100 Total assetsPrimary activitiesThe Company's activity consists of development, marketing and sale of software within Healthcare. Profit for the year amounts to DKK 13,287 thousand, which management considers satisfactory taking the world wide COVID 19 situation in mind. Equity amounts to DKK 14,719 thousand with an equity ratio of 73.82 %. Without affecting the high investment rate, an EBITDA of DKK 17,258 thousand has been realised, and in group level an EBITDA of 17,602 thousand has been realised, which is very satisfactory. The subsidiary, CareCom US inc. , is profitable and we will be staffing further to increase the growth. ​2021 was also the year where CareCom A/S sold it’s NLP project CareIndexing. CareCom group will continue to sell and market the product but its IP is sold. Product development We have continued to enhance and to strengthen the core part of our main product, HealthTerm. For 2021, this included an upgrade of the standards that HealthTerm is built on to the newest (HL7 FHIR) and adaption of HealthTerm to new customers. New products A new set of products to supplement HealthTerm was initiated the last years, and this is continued in 2021. This included CareTerms, which is an interface terminology (a large set of synonyms for the international code systems). Sales In 2021 we continued to focus on sales worldwide, and specially in US. The sales in US has increased around 72 %. This significant increase in new contracts is expected to continue the coming years. Also in Europe have we subscribed new contracts. Our sales staff has been strengthened also in these areas. Expectations for 2022 For 2022 Management expects increasing revenue, increasing investments in US market and an increasing profit compared to 2021. A positive development in revenue and profits is expected to be realized on all markets. Also, this development is expected to continue the coming years. Events after the balance sheet dateNo events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.24415105128090657156837704840569863969368416559629506697634412090263713668299650861755257216954256601669136667571125201132874994891490135000008000000-212501-3108510-21250113500000146106620579101461066205791010837821017310837821017316599231315803480635390000214055817058033710002397388611439978562651045536371225628740429077125419257001171218382952984515754290448916227937111997871993793915173673500000500000487500585000231123346124135000008000000147186239431124500000585000346124800000094311245000004875002311231350000029497943191329497943191304324740432474150346567941149621151525831125545740484570764028318192856156492433748781624924337531063619937939151736730-8000000-8000000-975009750001 Gross profit /lossPart of the company's software and technology has been sold to a group company, Careindexing ApS, this year. The sale has generated a profit of 10.3 million, which has been recognised as other income. Gross profit is hereby affected positively by this amount.2 Staff costs2021 DKK2020 DKKWages and salaries6,396,8676,271,453Pension costs446,608475,134Other social security costs96,78782,703Other staff costs216,575219,1157,156,8377,048,405Average number of full-time employees121112113 Other financial income 2021 DKK2020 DKKFinancial income from group enterprises131,32299,650Other interest income5,3600136,68299,6504 Other financial expenses2021 DKK2020 DKKOther interest expenses74,72223,477Exchange rate adjustments11,45329,09586,17552,572<br />2021 DKK2020 DKKOther interest expenses74,72223,477Exchange rate adjustments11,45329,09586,17552,5725 Tax on profit/loss for the year2021 DKK2020 DKKCurrent tax3,803,6961,255,457Change in deferred tax(136,934)(130,256)Adjustment concerning previous years(5)03,666,7571,125,2016 Intangible assetsCompleted development projects DKKCost beginning of year19,035,738Cost end of year19,035,738Amortisation and impairment losses beginning of year(16,977,828)Amortisation for the year(596,844)Amortisation and impairment losses end of year(17,574,672)Carrying amount end of year1,461,0667 Development projectsNo new development projects have been initiated during the financial year. During the year, HealthTerm has been maintained and adapted to new customers.8 Property, plant and equipmentOther fixtures and fittings, tools and equipment DKKCost beginning of year530,522Cost end of year530,522Depreciation and impairment losses beginning of year(320,349)Depreciation for the year(101,795)Depreciation and impairment losses end of year(422,144)Carrying amount end of year108,3789 Financial assetsInvestments in group enterprises DKKOther receivables DKKCost beginning of year3,533,061390,000Additions090,635Cost end of year3,533,061480,635Impairment losses beginning of year(2,217,258)0Exchange rate adjustments96,8080Share of profit/loss for the year247,3120Impairment losses end of year(1,873,138)0Carrying amount end of year1,659,923480,635Investments in subsidiariesRegistered inCorporate formEquity interest %CareCom US Inc.Delaware, USAInc.10010 Receivables from group enterprisesThe main parts of the receivables from group enterprises is expected to be settled within one year by proposed dividend.11 Deferred tax2021 DKK2020 DKKIntangible assets321,435452,740Property, plant and equipment(26,456)(20,827)Deferred tax294,979431,913<br />11 Deferred tax12 Unrecognised rental and lease commitments2021 DKK2020 DKKLiabilities under rental or lease agreements until maturity in total1,205,1001,950,00013 Contingent liabilitiesThe Entity participates in a Danish joint taxation arrangement where SPIP Holding ApS serves as the administration company. According to the joint taxation provisions of the Danish Corporation Tax Act, the Entity is therefore liable for income taxes etc for the jointly taxed entities, and for obligations, if any, relating to the withholding of tax on interest, royalties and dividend for the jointly taxed entities. The jointly taxed entities' total known net liability under the joint taxation arrangement is disclosed in the administration company's financial statements.This annual report has been presented in accordance with the provisions of the Danish Financial Statements Act governing reporting class B enterprises with addition of a few provisions for reporting class C.This annual report has been presented in accordance with the provisions of the Greenlandic Financial Statements Act governing reporting class B enterprises with addition of a few provisions for reporting class C.The accounting policies applied to these financial statements are consistent with those applied last year.falseConsolidated financial statementsReferring to section 110 of the Danish Financial Statements Act, no consolidated financial statements have been prepared.Recognition and measurementAssets are recognised in the balance sheet when it is probable as a result of a prior event that future economic benefits will flow to the Entity, and the value of the asset can be measured reliably. Liabilities are recognised in the balance sheet when the Entity has a legal or constructive obligation as a result of a prior event, and it is probable that future economic benefits will flow out of the Entity, and the value of the liability can be measured reliably. On initial recognition, assets and liabilities are measured at cost. Measurement subsequent to initial recognition is effected as described below for each financial statement item. Anticipated risks and losses that arise before the time of presentation of the annual report and that confirm or invalidate affairs and conditions existing at the balance sheet date are considered at recognition and measurement. Income is recognised in the income statement when earned, whereas costs are recognised by the amounts attributable to this financial year.Gross profit or lossGross profit or loss comprises revenue, other operating income and external expenses.RevenueRevenue from the sale of services is recognised in the income statement when delivery is made to the buyer. Revenue is recognised net of VAT, duties and sales discounts and is measured at fair value of the consideration fixed.Other operating incomeOther operating income comprises income of a secondary nature as viewed in relation to the Entity’s primary activities.Other external expensesOther external expenses include expenses relating to the Entity’s ordinary activities, including expenses for premises, stationery and office supplies, marketing costs, etc. This item also includes writedowns of receivables recognised in current assets.Staff costsStaff costs comprise salaries and wages, and social security contributions, pension contributions, etc for entity staff.Depreciation, amortisation and impairment lossesDepreciation, amortisation and impairment losses relating to property, plant and equipment and intangible assets comprise depreciation, amortisation and impairment losses for the financial year, and gains and losses from the sale of intangible assets and property, plant and equipment.Income from investments in group enterprisesIncome from investments in group enterprises comprises the pro rata share of the individual enterprises’ profit/loss after full elimination of intra-group profits or losses.Other financial incomeOther financial income comprises interest income, including interest income on receivables from group enterprises and transactions in foreign currencies.Other financial expensesOther financial expenses comprise interest expenses, including interest expenses on payables to group enterprises and transactions in foreign currencies.Tax on profit/loss for the yearTax for the year, which consists of current tax for the year and changes in deferred tax, is recognised in the income statement by the portion attributable to the profit for the year and recognised directly in equity by the portion attributable to entries directly in equity.The Entity is jointly taxed with all Danish group enterprises. The current Danish income tax is allocated among the jointly taxed entities proportionally to their taxable income (full allocation with a refund concerning tax losses).Intellectual property rights etcIntellectual property rights etc comprise development projects completed and in progress with related intellectual property rights, acquired intellectual property rights and prepayments for intangible assets.Development projects on clearly defined and identifiable products and processes, for which the technical rate of utilisation, adequate resources and a potential future market or development opportunity in the enterprise can be established, and where the intention is to manufacture, market or apply the product or process in question, are recognised as intangible assets. Other development costs are recognised as costs in the income statement as incurred. When recognising development projects as intangible assets, an amount equalling the costs incurred less deferred tax is taken to equity under Reserve for development costs that is reduced as the development projects are amortised and written down. ​ ​The cost of development projects comprises costs such as salaries and amortisation that are directly and indirectly attributable to the development projects. ​ Completed development projects are amortised on a straight-line basis using their estimated useful lives which are determined based on a specific assessment of each development project. If the useful life cannot be estimated reliably, it is fixed at 10 years. For development projects protected by intellectual property rights, the maximum period of amortisation is the remaining duration of the relevant rights. ​ ​Intellectual property rights etc are written down to the lower of recoverable amount and carrying amount.Property, plant and equipmentOther fixtures and fittings, tools and equipment are measured at cost less accumulated depreciation and impairment losses. Land is not depreciated. Cost comprises the acquisition price, costs directly attributable to the acquisition and preparation costs of the asset until the time when it is ready to be put into operation. The basis of depreciation is cost less estimated residual value after the end of useful life. Straight-line depreciation is made on the basis of the following estimated useful lives of the assets:Other fixtures and fittings, tools and equipment3-5 yearsEstimated useful lives and residual values are reassessed annually. Items of property, plant and equipment are written down to the lower of recoverable amount and carrying amount.Investments in group enterprisesInvestments in group enterprises are recognised and measured according to the equity method. This means that investments are measured at the pro rata share of the enterprises’ equity value plus unamortised goodwill and plus or minus unrealised intra-group profits or losses. Group enterprises with negative equity value are measured at DKK 0. Any receivables from these enterprises are written down to net realisable value based on a specific assessment. If the Parent has a legal or constructive obligation to cover the liabilities of the relevant enterprise, and it is probable that such obligation will involve a loss, a provision is recognised that is measured at present value of the costs necessary to settle the obligations at the balance sheet date. Upon distribution of profit or loss, net revaluation of investments in group enterprises is transferred to Reserve for net revaluation according to the equity method under equity. Investments in group enterprises are written down to the lower of recoverable amount and carrying amount.ReceivablesReceivables are measured at amortised cost, usually equalling nominal value, less writedowns for bad and doubtful debts.PrepaymentsPrepayments comprise incurred costs relating to subsequent financial years. Prepayments are measured at cost.CashCash comprises cash in hand and bank deposits.DividendDividend is recognised as a liability at the time of adoption at the general meeting. Proposed dividend for the financial year is disclosed as a separate item in equity. Extraordinary dividend adopted in the financial year is recognised directly in equity when distributed and disclosed as a separate item in Management's proposal for distribution of profit/loss.Deferred taxDeferred tax is recognised on all temporary differences between the carrying amount and the tax-based value of assets and liabilities, for which the tax-based value is calculated based on the planned use of each asset. However, no deferred tax is recognised for amortisation of goodwill disallowed for tax purposes and temporary differences arising at the date of acquisition that do not result from a business combination and that do not have any effect on profit or loss or on taxable income. Deferred tax assets, including the tax base of tax loss carryforwards, are recognised in the balance sheet at their estimated realisable value, either as a set-off against deferred tax liabilities or as net tax assets.Other financial liabilitiesOther financial liabilities are measured at amortised cost, which usually corresponds to nominal value.Joint taxation contributions payable or receivableCurrent joint taxation contributions receivable or joint taxation contributions payable are recognised in the balance sheet, calculated as tax computed on the taxable income of the year, which has been adjusted for prepaid tax. For tax losses, joint taxation contributions receivable are only recognised if such losses are expected to be used under the joint taxation arrangement.Deferred incomeDeferred income comprises income received for recognition in subsequent financial years. Deferred income is measured at cost.2022-02-16Jacob Boye Hansen